Socioeconomic disparities in musculoskeletal oncology.

J Surg Oncol · Sep 2023 · Review

Jawad MU, Theriault RV, Thorpe SW, Randall RL

Department of Orthopedic Surgery, UC Davis School of Medicine, Corvallis

Orthopaedic Oncology

SUMMARY — THE REDUCTIONReviews socioeconomic and insurance-related disparities across musculoskeletal oncology, spanning metastatic bone disease, hematologic malignancies, primary bone cancers, and soft tissue sarcomas.
Abstract, as published

Musculoskeletal oncology is a clinical specialty dealing with a diverse population of patients with metastatic bone disease, hematological malignancies with musculoskeletal manifestations, primary bone malignancies and soft tissue sarcomas. There are wide-spread disparities including socioeconomic (SES) and insurance-related disparities reported in the literature. In this review, we'll summarize the disparities surrounding the musculoskeletal oncology.

Featured in the 2026-10-23 issue.

← Musculoskeletal Effects of Antineoplastic Agents.

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.